Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (251-260 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis Research|October 1, 1975
Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogenD Collen, E B Ong, A J Johnson
Lancet (London, England)|March 4, 1978
Prediction of postoperative leg-vein thrombosis in gynaecological patientsI Rakoczi, D Chamone, D Collen, et al.
Thrombosis and Haemostasis|May 1, 1995
Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysisH R Lijnen, J M Stassen, D Collen
Thrombosis Research. Supplement|January 1, 1990
On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogenH R Lijnen, B Van Hoef, D Collen
Surgery, Gynecology & Obstetrics|August 1, 1980
The relevance of clinical and hemostasis parameters for the prediction of postoperative thrombosis of the deep veins of the lower extremity in gynecologic patientsI Rákóczi, D Chamone, M Verstraete, et al.
European Journal of Biochemistry|November 2, 1984
Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinaseH R Lijnen, B Van Hoef, D Collen
European Journal of Biochemistry|September 1, 1994
Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptorH R Lijnen, F De Cock, D Collen
Biochimica Et Biophysica Acta|January 12, 1983
Physicochemical, immunochemical and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factorH R Lijnen, D B Rylatt, D Collen
Arteriosclerosis (Dallas, Tex.)|January 1, 1988
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitusJ Auwerx, R Bouillon, D Collen, et al.
Biochemistry|August 11, 1987
Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive siteW E Holmes, H R Lijnen, D Collen
Pageof 72

Showing results (251-260 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis Research|October 1, 1975
Human plasminogen: in vitro and in vivo evidence for the biological integrity of NH2-terminal glutamic acid plasminogenD Collen, E B Ong, A J Johnson
Lancet (London, England)|March 4, 1978
Prediction of postoperative leg-vein thrombosis in gynaecological patientsI Rakoczi, D Chamone, D Collen, et al.
Thrombosis and Haemostasis|May 1, 1995
Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysisH R Lijnen, J M Stassen, D Collen
Thrombosis Research. Supplement|January 1, 1990
On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogenH R Lijnen, B Van Hoef, D Collen
Surgery, Gynecology & Obstetrics|August 1, 1980
The relevance of clinical and hemostasis parameters for the prediction of postoperative thrombosis of the deep veins of the lower extremity in gynecologic patientsI Rákóczi, D Chamone, M Verstraete, et al.
European Journal of Biochemistry|November 2, 1984
Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinaseH R Lijnen, B Van Hoef, D Collen
European Journal of Biochemistry|September 1, 1994
Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptorH R Lijnen, F De Cock, D Collen
Biochimica Et Biophysica Acta|January 12, 1983
Physicochemical, immunochemical and functional comparison of human histidine-rich glycoprotein and autorosette inhibition factorH R Lijnen, D B Rylatt, D Collen
Arteriosclerosis (Dallas, Tex.)|January 1, 1988
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitusJ Auwerx, R Bouillon, D Collen, et al.
Biochemistry|August 11, 1987
Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive siteW E Holmes, H R Lijnen, D Collen
Pageof 72